Dina Alnabwani

Dina Alnabwani practices at Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health.

Dina Alnabwani's NPI, 1376171447, was assigned on April 1, 2020. Dina Alnabwani holds New Jersey license 25MA11810700.

Dina Alnabwani's primary practice is Ocean University Medical Center, at 425 Jack Martin Blvd, Brick, NJ 08724 in Ocean County. The practice phone is (732) 840-2200.

Dina Alnabwani's primary practice is Ocean University Medical Center in Brick, New Jersey, part of Hackensack Meridian Health. Dina Alnabwani is also affiliated with Jersey Shore University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dina Alnabwani to 3 more hospitals, 3 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dina Alnabwani practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dina Alnabwani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dina Alnabwani is licensed in New Jersey.

CMS data shows 2,319 Medicare services from Dina Alnabwani across 8 procedure codes in 2024, for 696 Medicare patients. Medicare paid $219,848 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 696 Medicare patients who saw Dina Alnabwani in 2024. The largest group is 65 to 74, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dina Alnabwani's median patient age at 71, with 53% women.

In 2024, Dina Alnabwani wrote 674 Medicare Part D claims for 223 patients. 87% of them were for generic drugs. CMS names the drug for 335 of them, across 18 drugs with 11 or more claims each, at $20,828 in total drug cost.

Dina Alnabwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dina Alnabwani, published from 2021 to 2023. 2022 was the busiest year, with 13. Dina Alnabwani has published most often in Cureus. Dina Alnabwani's most frequent co-authors are Sharon Hechter, MD, Gustavo Delaluz, MD and Bassam I. Hasan, MD.

CMS Open Payments shows 4 general payments to Dina Alnabwani from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $94.